Early Diagnosis of ABCB11 Spectrum Liver Disorders by Next Generation Sequencing.
10.5223/pghn.2017.20.2.114
- Author:
Su Jeong LEE
1
;
Jung Eun KIM
;
Byung Ho CHOE
;
An Na SEO
;
Han Ik BAE
;
Su Kyeong HWANG
Author Information
1. Department of Pediatrics, Kyungpook National University School of Medicine, Daegu, Korea. neurobaby79@gmail.com
- Publication Type:Original Article
- Keywords:
Cholestasis;
Jaundice;
Hyperbilirubinemia;
ABCB11;
Mutation;
High-throughput nucleotide sequencing
- MeSH:
Biliary Atresia;
Choledochal Cyst;
Cholestasis;
Cholestasis, Intrahepatic;
Diagnosis;
Early Diagnosis*;
Exome;
Genetic Counseling;
Hepatitis;
High-Throughput Nucleotide Sequencing;
Humans;
Hyperbilirubinemia;
Jaundice;
Liver Transplantation;
Liver*;
Metabolic Diseases;
Parenteral Nutrition, Total;
Syphilis, Congenital
- From:Pediatric Gastroenterology, Hepatology & Nutrition
2017;20(2):114-123
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: The goal of this study was the early diagnosis of ABCB11 spectrum liver disorders, especially those focused on benign recurrent intrahepatic cholestasis and progressive familial intrahepatic cholestasis. METHODS: Fifty patients presenting neonatal cholestasis were evaluated to identify underlying etiologies. Genetic analysis was performed on patients suspected to have syndromic diseases or ABCB11 spectrum liver disorders. Two families with proven ABCB11 spectrum liver disorders were subjected to genetic analyses to confirm the diagnosis and were provided genetic counseling. Whole exome sequencing and Sanger sequencing were performed on the patients and the family members. RESULTS: Idiopathic or viral hepatitis was diagnosed in 34%, metabolic disease in 20%, total parenteral nutrition induced cholestasis in 16%, extrahepatic biliary atresia in 14%, genetic disease in 10%, neonatal lupus in 2%, congenital syphilis in 2%, and choledochal cyst in 2% of the patients. The patient with progressive familial intrahepatic cholestasis had novel heterozygous mutations of ABCB11 c.11C>G (p.Ser4*) and c.1543A>G (p.Asn515Asp). The patient with benign recurrent intrahepatic cholestasis had homozygous mutations of ABCB11 c.1331T>C (p.Val444Ala) and heterozygous, c.3084A>G (p.Ala1028Ala). Genetic confirmation of ABCB11 spectrum liver disorder led to early liver transplantation in the progressive familial intrahepatic cholestasis patient. In addition, the atypically severe benign recurrent intrahepatic cholestasis patient was able to avoid unnecessary liver transplantation after genetic analysis. CONCLUSION: ABCB11 spectrum liver disorders can be clinically indistinguishable as they share similar characteristics related to acute episodes. A comprehensive genetic analysis will facilitate optimal diagnosis and treatment.
